Attorney General Baker Announces Nationwide Settlement Against Manufacturer of Cardizem Heart Medication
Attorney General Thurbert Baker announced a proposed settlement today for $80 million involving the popular heart medication Cardizem CD. The fifty state settlement resolves an antitrust lawsuit filed by Baker and other state attorneys general against Aventis Pharmaceuticals Inc. (“Aventis”), Andrx Corporation (“Andrx”) and affiliated entities. Attorney General Baker had charged that Aventis and Andrx illegally agreed that Andrx would stay off the market with a less expensive generic version of the drug Cardizem CD in return for Aventis paying Andrx nearly $90 million. Delays in bringing the generic drug to market, the lawsuit alleged, resulted in higher prices for consumers and governmental agencies. “Today’s settlement sends a clear warning to prescription drug companies trying to boost profits at consumer expense.” Baker stated. “If you illegally conspire to keep less expensive medications out of the hands of Georgia consumers, I will make you answer for your actions in court.” Under the settlement, Aventis and Andrx must pay $80 million into a fund that will compensate consumers, state agencies, and insurance companies who overpaid for Cardizem CD and its generic equivalents between 1998 and January 2003. The settlement is in addition to a $110 million settlement reached earlier between the companies and drug wholesalers involving the same alleged violations. In total, the drug companies will be required to pay over $190 million. The proposed settlement was filed today with U.S. Federal District Court Judge Nancy Edmunds in Detroit and requires approval from the court to become effective. If approved, Attorney General Baker will implement a claims administration process this summer for consumers who purchased Cardizem CD or its generic equivalent at any time between January of 1998 and January 2003.